ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System
- New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands planned for later this summer
- Enables insulin automation to be controlled directly from the user’s smartphone, rather than a separate dedicated handset
- Starting on Kaleido today with Diabeloop’s DBLG1 algorithm is the fastest path to Kaleido with DBLG2 and Dexcom G7
Utrecht, the Netherlands — May 12, 2026
ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced the commercial launch of its new smartphone-controlled hybrid closed loop system, with first commercial deliveries in Germany and the Netherlands planned for later this summer.
